XML 30 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Operating expenses    
Research and development $ 1,648 $ 2,989
General and administrative 1,730 1,886
Total operating expenses 3,378 4,875
Loss from operations (3,378) (4,875)
Other income (expense), net 30 (6)
Warrant inducement expense (4,829)  
Net loss and comprehensive loss $ (8,177) $ (4,881)
Net loss per share, basic and diluted $ (0.47) $ (0.52)
Weighted-average common shares outstanding, basic and diluted 17,267,123 9,427,073